News
New analysis from the EARLY TAVR trial showed patients between the age of 65 and 70 years old derived the most benefits of a ...
2d
MedPage Today on MSNFDA Approves Sapien 3 TAVR for Asymptomatic Aortic StenosisFDA approved the Sapien 3 transcatheter aortic valve replacement (TAVR) platform for treatment of severe aortic stenosis ...
The Society of Thoracic Surgeons (STS) today announced the launch of its latest surgical risk calculator designed for patients undergoing ascending aorta and aortic root surgery, with or without ...
April 14, 2025—With a focus on endovascular aneurysm repair (EVAR) for abdominal aortic aneurysms (AAAs) and thoracoabdominal aortic aneurysms (TAAAs), The VIVA Foundation convened a Vascular Leaders ...
Endovascular repair of infrarenal abdominal aortic aneurysms (EVAR) has become a widely accepted treatment modality. The conventional approach of an EVAR involves bilateral groin incisions to ...
In this study we incorporated different types of aortic root motion into fluid-structure interaction (FSI) models representing an ATAA and a healthy aorta to examine their impacts on wall stress and ...
The present study aims to characterize racial disparities in long-term outcomes, perioperative outcomes, and health care use after endovascular aortic aneurysm repair. We conducted a retrospective ...
Department of Surgery, Division of Vascular and Endovascular Surgery, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA (A.A.-S., M.A.H.). Center for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results